| Bristol-Myers Squibb SA - Onureg 300 mg, Filmtabletten | | 67802 | | 02 | | Onureg 300 mg | | Filmtabletten | | L01BC07 | | Azacitidine | | 16.09.2021 | | |
| | Composition | | azacitidinum 300 mg, mannitolum, cellulosum microcristallinum silicificatum, carmellosum natricum conexum corresp. natrium 1.8 mg, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum 5.42 mg, macrogolum 4000, triacetinum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum) pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Azacitidine | 300 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Nigrum) pro Compresso Obducto | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum Silicificatum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 5.42 mg | | | Macrogol | 4000 | | | Magnesii Stearas | | | | Mannitol | | | | Triacetinum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 7 | PR | PR | A | | Yes | | 004 | 14 | PR | PR | A | | Yes |
|
|
